First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck

Featuring an interview with Prof Martin Reck, including the following topics:Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunotherapy and maintenance lurbinectedin/atezolizumab (0:00)Biology of small cell lung cancer and pharmacodynamics of systemic treatment (3:25)Considerations with maintenance therapy for ES-SCLC (9:31)Considerations with immunotherapy for ES-SCLC (13:12)Curability of SCLC with systemic therapy (15:17)Data with chemoimmunotherapy for patients with poor performance status (25:55)Future developments in therapy for SCLC (30:11)Rapid fire: Small Cell 101 (35:45)CME information and select publications

NOW PLAYING

0:00 40:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

Lifetime Mortgages The Strategy Property Owners Need to Understand

Apr 10, 2026 ·42m

From Property to Bitcoin Mining The Future of Investing & Energy

Mar 28, 2026 ·31m

10 Rental Properties or Bitcoin The Investment Debate Everyone's Ignoring

Mar 27, 2026 ·33m

Sales Slowing Rents Rising Real Data on Sales, Rents & Risk

Mar 13, 2026 ·30m

Who Wins Next The Landlords Who Will Thrive and Those Who Won't

Mar 1, 2026 ·27m

The Great Landlord Reset What Just Changed

Feb 28, 2026 ·35m

Similar Podcasts

The Laura Ingraham Show Laura Ingraham The most-watched woman in the history of cable news brings her no-holds-barred political and cultural commentary to podcasting with The Laura Ingraham Show. A bestselling author, breast cancer survivor, and mother of three internationally adopted children, Laura was the most listened-to woman in talk radio before launching her own podcast. A trailblazer across media platforms, she brings a unique perspective to this twice-weekly show, drawing on her experience as a white-collar criminal defense litigator and a Supreme Court law clerk.New episodes drop twice a week—delivering the clarity, courage, and common sense America needs. Lynne's Podcast Lynne August MD Dr. A offers her interpretations and applications of Dr. Revici’s profound research at DrRevici.com and the Revici Journal. Dr. Revici was arguably fifty to one hundred years ahead of his time in his application of quantum physics to medical sciences. As a once-aspiring physicist, this alone propelled Dr. A to Dr. Revici. As a physician, she felt compelled, and in some palpable way responsible, to understand Dr. Revici’s ability to control pain and achieve remissions in terminal cancer patients with his non-toxic “guided chemotherapy”, even many cancers that conventional therapy failed to control. Most of the time his questions and solutions were as unprecedented as they were effective. While Dr. Revici was primarily focused on cancer, Dr. A’s research and therapeutics to prevent and treat all chronic and degenerative disease can transform 21st century medicine. Agrifood Brief Euractiv Welcome to EURACTIV's AgriFood Brief, your weekly update on all things Agriculture & Food in the EU from EURACTIV's Agrifood news team: Gerardo Fortuna and Natasha Foote

Frequently Asked Questions

How long is this episode of Lung Cancer Update?

This episode is 40 minutes long.

When was this Lung Cancer Update episode published?

This episode was published on June 18, 2026.

What is this episode about?

Can I download this Lung Cancer Update episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!